AG2R La Mondiale Gestion d'Actifs’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.2M Buy
35,218
+3,048
+9% +$3.11M 1.53% 12
2026
Q1
$29.6M Buy
32,170
+285
+0.9% +$289K 1.35% 12
2025
Q4
$34.3M Buy
31,885
+1,946
+6% +$1.86M 1.52% 11
2025
Q3
$23.3M Hold
29,939
1.2% 12
2025
Q2
$23.3M Buy
29,939
+227
+0.8% +$176K 1.2% 12
2025
Q1
$21.9M Buy
+29,712
New +$24.7M 1.19% 13

Other funds holding LLY

AG2R La Mondiale Gestion d'Actifs's LLY Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Eli Lilly (LLY) stake by 9.5% in Q2 2026, buying an estimated $3.11M and bringing the position to 35,218 shares worth $42.2M. The position accounts for 1.53% of the portfolio, ranked #12.

AG2R La Mondiale Gestion d'Actifs first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • AG2R La Mondiale Gestion d'Actifs held 35,218 shares of Eli Lilly worth $42.2M as of Q2 2026.
  • AG2R La Mondiale Gestion d'Actifs bought 3,048 Eli Lilly shares in Q2 2026, an estimated $3.11M.
  • Eli Lilly made up 1.53% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #12 holding.
  • AG2R La Mondiale Gestion d'Actifs first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.